Effect of Peppermint (Mentha Piperita) on severity of symptoms in patients with irritable bowel syndrome

Comparison of the effect of Peppermint (Mentha Piperita) with placebo on severity of symptoms in patients with irritable bowel syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130731014229N10

Enrollment

Registered

2019-10-31

Start date

2019-04-21

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: in addition to the medications prescribed by the physician, the amount of 10 drops of mint extract of Barij Essence Company is given twice a day after lunch and din

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The desire to participate in the study Aged 18 to 65 Gastrointestinal intestinal syndrome is diagnosed by a gastroenterologist

Exclusion criteria

Exclusion criteria: history of any major bowel surgery metabolic diseases or other diseases taking corticosteroids taking Non-steroidal anti-inflammatory drugs

Design outcomes

Primary

Measure	Time frame
Severity of symptoms of irritable bowel syndrome. Timepoint: Before the intervention and one month after the intervention. Method of measurement: Gastrointestinal Symptom Rating Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Jafarianesh

Arak University of Medical Sciences

nurse_science@yahoo.com+98 86 3417 3503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026